Research - The buyout rumors around Depomed (DEPO) continue to swirl, with DealReporter on Wednesdaymorning saying that the company is in discussion with suitors. Depomed rebuked Horizon … Continue Reading
PremiumResearch - Marinus Pharmaceuticals (MRNS) finally released top-line results from their small study of ganaxolone in PCDH19 this morning. Recall we covered this in our August webinar … Continue Reading
PremiumResearch - A few quick updates from our CNS webinar last month. Sage Therapeutics (SAGE) announced that SAGE-547 has received Breakthrough Therapy Designation for Postpartum Depression based … Continue Reading
PremiumResearch - It was just over one year ago that Tekmira Pharmaceuticals (TKMR) changed its name to Arbutus Biopharma (ABUS), and its focus to HBV, moving away from … Continue Reading
Read nowResearch - We’ve been discussing the potential for biotech to play some catchup to the broader market in our monthly webinars of late, and the move is … Continue Reading
PremiumResearch - A last-minute trade idea for this slow Friday afternoon. As most healthcare investors will be aware, Sanofi (SNY) has made public their desire to purchase … Continue Reading
PremiumResearch - Sage Therapeutics’s (SAGE) Postpartum Depression results are stellar. Even with a smaller sample size (21 patients as opposed to an enrollment goal of 32), SAGE-547 … Continue Reading
Premium
